← Eichor
Study identifier: NCT02586389 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Condition: Non-hematologic Cancer  ·  Sponsor: Sequenom, Inc.

PhaseN/A
Planned participants3000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This specimen collection is designed to obtain whole blood and tumor tissue from subjects diagnosed with cancer for the purpose of the development of a noninvasive liquid biopsy assay using next generation sequencing (NGS).

This description comes directly from the study's public registry record.

Talk to the study team

Graham McLennan  ·  (858) 202-9162  ·  gmclennan@sequenom.com

Always discuss trial participation with your own doctor first.

Locations (1)

Idaho UrologyBoise, Idaho, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02586389